-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - Topic Brief: Antenatal Care
1
Topic Brief: Antenatal Care
Date: 6/30/2020
Nomination Number: 0902
Purpose: This document summarizes the information addressing a nomination submitted on
April 7, 2020 through the Effective Health Care Website. This information was used to inform
the Evidence-based Pract…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
June 21, 2019 - Can Physical Activity Improve the Health of Wheelchair Users? Amended Protocol
Evidence-based Practice Center Systematic Review Protocol
Project Title: Can Physical Activity Improve the Health of Wheelchair Users?
A Systematic Review
Initial publication date: April 12, 2019
Amendment Date: June 21, 2019…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (…
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is
part of AHRQ’s Effective Health Care program. It is a collaborative network of research
centers that support the rapid development o…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - 1
Comparative Effectiveness Review
Number 105
Interventions To Improve Cardiovascular Risk
Factors in People With Serious Mental Illness
Executive Summary
Background
Serious mental illness (SMI) is
defined generally as a major mental
or behavioral disorder, causing
substantial impairment in multiple areas …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - KQ1_IgG Duration_n=3
Observational studies examining IgG Duration
Author Year Title PMID Link/URL Country Study Design Length of follow-up (Months) Population category Population Description Data Source Study Period Inclusion criteria Exclusion criteria Total N Age: Mean (SD) years or Median (IQR) Race stratifi…
-
effectivehealthcare.ahrq.gov/products/mental-illness-heart/research
April 22, 2013 - Current Page Topic Timeline Oct. 28, 2011 Topic Initiated Jan. 17, 2012 Research Protocol Apr. 22, 2013 Systematic Review Aug. 9, 2013 Disposition of Comments Report Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness
Systematic Review Archived April 22, 2013 Web Version [NLM…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - Effective Health Care
Topic Number: 0404
Document Completion Date: 08-27-12
1
Prevention of Contrast-Induced Nephropathy
Nomination Summary Document
Results of Topic Selection Process & Next Steps
Prevention of contrast-induced nephropathy will go forward for refinement as a systematic revi…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
October 01, 2021 - Comparative Effectiveness Review No. 241_Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury
Comparative Effectiveness Review
Number 241
Physical Activity and the Health of Wheelchair
Users: A Systematic Review in Multiple Scle…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
April 18, 2012 - Evidence-based Practice Center Systematic Review Protocol
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Strategies To Improve Cardiovascular Risk Factors in People With Serious
Mental Illness: A Comparative Effectiveness Review
Amendment Date(s):
Amendment 1 – January 20, 20…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - CI: 0.12,
72.49
Metabolism and
nutrition disorders:
1/710, 3/701
RR = 0.43; CI: 0.03,
3.17
Diabetic … ketoacidosis:
1/710, 1/701
RR = 0.99; CI:0.06,
15.76
Diabetic metabolic
decompensation:
0/710 … /526
RR = 0.34; CI: 0.01,
8.23
Respiratory failure:
0/523, 1/526
RR = 0.34; CI: 0.01,
8.23
Diabetic … Schizophrenia: 1/1627,
0/1643
RR = 3.03, CI: 0.12,
74.27
Mania: 0/1627, 1/1643
RR = 0.34; CI: 0.01,
8.26
Diabetic … 0.01,
3.98
Metabolism and
nutrition disorders
Acidosis: 1/295, 0/143
RR = 1.46; CI: 0.06,
35.49
Diabetic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of Inhaled Cannabis on Painful
Diabetic Neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
February 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of Inhaled Cannabis on Painful
Diabetic Neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0.pdf
March 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of Inhaled Cannabis on Painful
Diabetic Neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of inhaled cannabis on painful
diabetic neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of inhaled cannabis on painful
diabetic neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of Inhaled Cannabis on Painful
Diabetic Neuropathy.
-
effectivehealthcare.ahrq.gov/products/children-special-needs-transition/technical-brief
June 17, 2014 - Current Page Topic Timeline Jan. 7, 2013 Topic Suggestion Oct. 24, 2013 Research Protocol Jun. 17, 2014 Technical Brief Sep. 17, 2014 Disposition of Comments Report Transition Care for Children With Special Health Needs
Technical Brief Archived June 17, 2014 Web Version [NLM Site] Download Main Document PDF 1.1 MB…
-
effectivehealthcare.ahrq.gov/products/health-data-mapping/protocol
December 03, 2019 - Current Page Topic Timeline May. 21, 2019 Topic Initiated Dec. 3, 2019 Research Protocol Mar. 1, 2021 Technical Brief Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes
Research Protocol December 3, 2019 Download Main Document PDF 141.8 KB
On March …
-
effectivehealthcare.ahrq.gov/products/mental-illness-heart/research-protocol
January 17, 2012 - Current Page Topic Timeline Oct. 28, 2011 Topic Initiated Jan. 17, 2012 Research Protocol Apr. 22, 2013 Systematic Review Aug. 9, 2013 Disposition of Comments Report Strategies To Improve Cardiovascular Risk Factors in People With Serious Mental Illness: A Comparative Effectiveness Review
Research Protocol Archive…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - Major: mortality, cerebrovascular disease-related events, development of
diabetes mellitus, diabetic … Major: mortality, cerebrovascular disease-
related events, development of diabetes
mellitus, diabetic … adverse events: mortality, cerebrovascular disease-related events,
development of diabetes mellitus, diabetic